Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy.
Article in Cancer Immunology, Immunotherapy (September 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Characterization of Pre- and Post-treatment Soluble Immune Mediators and the Tumor Microenvironment in NSCLC Patients Receiving PD-1/L1 Inhibitor Monotherapy
Preprint in Research Square (March 2024)
Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance
Article in Stem Cell Reviews and Reports (July 2023)